<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03647332</url>
  </required_header>
  <id_info>
    <org_study_id>2018Stolzenberg</org_study_id>
    <nct_id>NCT03647332</nct_id>
  </id_info>
  <brief_title>Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections</brief_title>
  <official_title>Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a single-center, prospective, single-blinded randomized clinical trial to
      investigate the effectiveness of using cooled RFA for the treatment of OA hip pain and
      function in subjects treated with cooled RFA compared with standard of care intra-articular
      steroid injections
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>24 weeks following treatment</time_frame>
    <description>Visual Analog Scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Osteo Arthritis of Hip</condition>
  <arm_group>
    <arm_group_label>Cooled RFA treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Steroid injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cooled RFA treatment</intervention_name>
    <description>cooled radiofrequency ablation</description>
    <arm_group_label>Cooled RFA treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid Drug</intervention_name>
    <description>steroid injection</description>
    <arm_group_label>Steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects presenting with radiographic evidence of hip OA and demonstrating hip pain
             for at least 30 days will be targeted. Radiographic evidence of hip OA is defined as
             Kellegran-Lawrence grade 2-4

          -  Not an operative candidate as per RI joint replacement surgeon OR

          -  Subjects who do not desire joint replacement surgery after consultation with RI joint
             replacement surgeon

          -  Male or non-pregnant female older than 18 years of age

          -  willing and able to sign the IRB-approved informed consent document.

        Exclusion Criteria:

          -  Any steroid injection in hip within 90 days

          -  Local infection at injection site or active systemic infection

          -  Anticoagulation status with inability to discontinue medication for appropriate
             duration for nerve blocks and RFA given proximity to major artery. (No anticoagulation
             contraindications for joint injection)

          -  AICD with inability to utilize magnet for RFA per treating cardiologist

          -  Body habitus does not allow for placement of longest needles and electrodes
             (approximately 15cm) to successfully administer treatment

          -  Allergy or severe renal impairment precluding iodionated contrast or magnavist
             injection despite standard premedication protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Morrison</last_name>
      <phone>267-339-7818</phone>
      <email>tiffany.morrison@rothmaninstitute.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2018</study_first_posted>
  <last_update_submitted>August 23, 2018</last_update_submitted>
  <last_update_submitted_qc>August 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

